CLYM
Climb Bio
CLYM
CLYM
80 hedge funds and large institutions have $221M invested in Climb Bio in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 23
Holders
80
Holding in Top 10
–
Calls
$669K
Puts
–
Top Buyers
| 1 | +$8.82M | |
| 2 | +$5.65M | |
| 3 | +$3.95M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.71M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.05M |
Top Sellers
| 1 | -$4.82M | |
| 2 | -$3.79M | |
| 3 | -$3.46M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.96M |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
-$2.64M |
